Sarcopenia and malnutrition in acutely ill hospitalized elderly: Prevalence and outcomes.

Clin Nutr

Department of Health Sciences, University of Milano-Bicocca, Italy; Geriatric Clinic, San Gerardo Hospital, Monza, Italy; Milan Center for Neuroscience (Neuro-Mi), Milan, Italy.

Published: August 2015

Background & Aims: Data about the prevalence of sarcopenia among hospitalized patients is lacking and it is unclear whether the diagnostic criteria commonly used in community-dwellers is applicable in acutely ill subjects. The aims of this report are: (i) to assess the prevalence of sarcopenia among hospitalized patients; (ii) to assess whether the European Working Group on Sarcopenia in Older People (EWGSOP) criteria are applicable in an acute care setting; and (iii) to assess the mortality rate at 3 months.

Methods: 103 patients admitted to the Acute Geriatric Clinic were enrolled. Inclusion criteria were: age ≥65 years and malnutrition or risk of malnutrition, according to the Mini Nutritional Assessment Short Form. Sarcopenia was diagnosed using the EWGSOP criteria by means of bioimpedance analysis, handgrip strength and gait speed, within 72 h of admission. Information on deaths was obtained by telephone interview at 3 months following discharge.

Results: Sarcopenia was diagnosed in 22 patients (21.4%). Twenty-three patients (22.3%) were not able to perform the gait speed and/or the handgrip strength because bedridden or requiring intensive treatments. In this group, a definite diagnosis of sarcopenia was not possible, lacking at least one EWGSOP criteria. Eleven (10.7%) patients died within the 3 months post-discharge period. Kaplan-Meier survival curves showed that sarcopenic patients died significantly more frequently than others (log-rank p ≤ 0.001).

Conclusions: In a population of hospitalized elderly malnourished or at risk of malnutrition, sarcopenia is highly prevalent and associated with an increased risk to die in the short-term. Furthermore, the EWGSOP criteria cannot be satisfactorily applied in a relevant proportion of patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnu.2014.08.015DOI Listing

Publication Analysis

Top Keywords

ewgsop criteria
16
sarcopenia
8
acutely ill
8
hospitalized elderly
8
prevalence sarcopenia
8
sarcopenia hospitalized
8
patients
8
hospitalized patients
8
risk malnutrition
8
sarcopenia diagnosed
8

Similar Publications

Muscle mass has been traditionally assessed by measuring paraspinal muscle areas at the level of the third lumbar vertebra on computed tomography (CT). Neurological or neurosurgical patients seldom undergo CT scans of the lumbar region. Instead, temporal muscle thickness (TMT), cross-sectional area (TMA) and radiodensity measured from head CT scans are readily available measures of muscle mass and quality in these patient cohorts.

View Article and Find Full Text PDF

Genetic Influence of the Brain on Muscle Structure: A Mendelian Randomization Study of Sarcopenia.

J Cachexia Sarcopenia Muscle

February 2025

Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Article Synopsis
  • - The study investigates the relationship between brain structure and function and sarcopenia-related traits, aiming to clarify how brain factors may influence muscle loss and strength in older adults.
  • - Data from the UK Biobank and GTEx Consortium involved over 8,400 participants, using advanced statistical methods to analyze genetic and imaging data for their impact on muscle metrics like lean mass and grip strength.
  • - Findings revealed numerous brain imaging phenotypes that causally impact lean mass and strength, highlighting the complex interplay between neurological health and muscle deterioration.
View Article and Find Full Text PDF

Assessment of muscle strength in elderly as a screening method for sarcopenia in primary care: a scoping review.

BMJ Open

November 2024

Unit of Physiotherapy, Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Objectives: To identify and map the available evidence for whether a test of handgrip strength (HGS) and/or the chair stand test (CST) have been used as screening tools for the detection of sarcopenia in elderly individuals within primary care settings.

Design: This study was designed as a scoping review, in accordance with the methodological framework for scoping reviews, developed by Arksey and O'Malley, and using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews.

Data Sources: A literature search was conducted to identify relevant articles listed in PubMed and Scopus databases up to 16 October 2023.

View Article and Find Full Text PDF

The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study.

J Cachexia Sarcopenia Muscle

December 2024

Department of Geriatrics, First Affiliated Hospital of Fujian Medical University, Institute of Neuroscience, Fujian Medical University, Fuzhou, China.

Article Synopsis
  • The study explored the effect of inhibiting SGLT1 on frailty and sarcopenia in older adults, aiming to understand its potential benefits.
  • A two-sample Mendelian randomization analysis showed that SGLT1 inhibition led to a decrease in frailty index and a lower risk of weak grip strength in individuals aged 60 and over.
  • Findings identified insulin resistance and various proteins and metabolites as mediators, suggesting that targeting SGLT1 could be a promising therapeutic approach for improving health in older adults.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how common sarcopenia (muscle loss) is in post-menopausal women with rheumatoid arthritis (RA) and its relationship with disease factors.
  • Out of 80 RA patients, 39% were found to have sarcopenia, while none of the control group had it, indicating a significant difference.
  • Sarcopenic RA patients exhibited lower body mass index (BMI), physical activity levels, muscle mass, and handgrip strength compared to non-sarcopenic patients, with only IGF-1 levels showing a notable difference between the two RA patient groups.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!